Ronald Blue Trust, Inc. Castle Biosciences Inc Transaction History
Ronald Blue Trust, Inc.
- $7.98 Billion
- Q3 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Castle Biosciences Inc stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 956 shares of CSTL stock, worth $29,473. This represents 0.0% of its overall portfolio holdings.
Number of Shares
956
Previous 956
-0.0%
Holding current value
$29,473
Previous $20,000
35.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CSTL
# of Institutions
200Shares Held
25.9MCall Options Held
292KPut Options Held
30.3K-
Black Rock Inc. New York, NY3.04MShares$93.9 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.83MShares$56.3 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.75MShares$53.9 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.54MShares$47.4 Million0.03% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.26MShares$38.9 Million0.61% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $811M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...